York-based Abingdon Health has announced the launch of a new “world first” blood test designed to enable paramedics to more quickly identify strokes.

Abingdon Health plc (LSE:ABDX), a specialist in the development and manufacture of lateral flow diagnostics, has highlighted ...

Panther Metals (LSE:PALM) has released a fifth set of assay results from its Vibracore sampling campaign at the Winston ...

A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in ...

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...

Q1 2026 earnings call: record free cash flow, accelerating output, cost cuts, and debt paydown amid Waha volatility—read ...

Sepsis remains a substantial disease burden worldwide, and patients can deteriorate rapidly, but the current diagnostics take ...

Cash Flow: Adjusted Funds Flow of $128 million ($0.27 per share). Cash flow from operating activities of $102 million. Free Cash Flow of $20 million from Athabasca (Thermal Oil) demonstrates the ...

A new study has unveiled a new method to cost-effectively and practically test for "forever chemicals" in water, potentially ...

The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...

The Capstone’s updated interior is the primary talking point.

But the real winner from Leicester City’s demise—a club outside English soccer’s traditional elite—are the established clubs ...